ctrl K

Price Alert

Kairos Pharma Ltd. (KAPA)

AMEX: KAPA · Real-Time Price · USD

1.19

-0.05 (-4.03%)

At close: Aug 15, 2025, 3:59 PM

1.22

2.68%

After-hours: Aug 15, 2025, 07:54 PM EDT

Kairos Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.27M	93K	437K	73K
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.38M	482K	57K	n/a
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	38K	n/a	n/a	n/a
Total Current Assets	4.17M	101K	437K	73K
Property-Plant & Equipment	n/a	n/a	n/a	n/a
Goodwill & Intangibles	222K	382K	542K	702K
Total Long-Term Assets	1.6M	864K	599K	702K
Total Assets	5.77M	965K	1.04M	775K
Account Payables	992K	2.4M	1.63M	1.55M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	4K	4K	380K
Other Current Liabilities	n/a	n/a	n/a	14K
Total Current Liabilities	992K	2.4M	1.63M	1.94M
Long-Term Debt	n/a	638K	582K	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	638K	582K	n/a
Total Liabilities	992K	3.04M	2.21M	1.94M
Total Debt	n/a	638K	582K	380K
Common Stock	14K	11K	10K	10K
Retained Earnings	-8.81M	-6.21M	-4.4M	-3.35M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	4.78M	-2.08M	-1.18M	-1.17M
Total Investments	n/a	n/a	n/a	n/a